Symptomatic therapy in multiple sclerosis: Big pharma should do more - YES

Aksel Siva, Orhun H Kantarci

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)980-982
Number of pages3
JournalMultiple Sclerosis
Volume21
Issue number8
DOIs
StatePublished - 2015

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this